Transgenic mice homozygous for Arf loss (p19Arfnull) succumb to spontaneously-developed tumors of a wide spectrum, including sarcomas, lymphomas, carcinomas and nervous system cancers, within a year (Kamijo et al., 1997; Kamijo et al., 1999). The gene discussed is CDKN2A; the disease is lymphoma.